• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人病原性链球菌蛋白质组学与疫苗开发。

Human pathogenic streptococcal proteomics and vaccine development.

机构信息

School of Biological Sciences, University of Wollongong, Wollongong, New South Wales, Australia.

出版信息

Proteomics Clin Appl. 2008 Mar;2(3):387-410. doi: 10.1002/prca.200780048.

DOI:10.1002/prca.200780048
PMID:21136841
Abstract

Gram-positive streptococci are non-motile, chain-forming bacteria commonly found in the normal oral and bowel flora of warm-blooded animals. Over the past decade, a proteomic approach combining 2-DE and MS has been used to systematically map the cellular, surface-associated and secreted proteins of human pathogenic streptococcal species. The public availability of complete streptococcal genomic sequences and the amalgamation of proteomic, genomic and bioinformatic technologies have recently facilitated the identification of novel streptococcal vaccine candidate antigens and therapeutic agents. The objective of this review is to examine the constituents of the streptococcal cell wall and secreted proteome, the mechanisms of transport of surface and secreted proteins, and describe the current methodologies employed for the identification of novel surface-displayed proteins and potential vaccine antigens.

摘要

革兰氏阳性链球菌是无动力、链状形成的细菌,通常存在于温血动物的正常口腔和肠道菌群中。在过去的十年中,一种结合了 2-DE 和 MS 的蛋白质组学方法被用于系统地绘制人类致病性链球菌物种的细胞、表面相关和分泌蛋白图谱。完整的链球菌基因组序列的公开可用性以及蛋白质组学、基因组学和生物信息学技术的融合,最近促进了新型链球菌疫苗候选抗原和治疗剂的鉴定。本综述的目的是检查链球菌细胞壁和分泌蛋白质组的组成、表面和分泌蛋白的运输机制,并描述目前用于鉴定新型表面展示蛋白和潜在疫苗抗原的方法。

相似文献

1
Human pathogenic streptococcal proteomics and vaccine development.人病原性链球菌蛋白质组学与疫苗开发。
Proteomics Clin Appl. 2008 Mar;2(3):387-410. doi: 10.1002/prca.200780048.
2
Immunoproteomic assay of extracellular proteins in Streptococcus equi ssp. zooepidemicus.马链球菌兽疫亚种胞外蛋白的免疫蛋白质组学分析
FEMS Microbiol Lett. 2008 Sep;286(1):103-9. doi: 10.1111/j.1574-6968.2008.01259.x.
3
Current methodologies for proteomics of bacterial surface-exposed and cell envelope proteins.当前用于细菌表面暴露和细胞包膜蛋白的蛋白质组学方法。
Proteomics. 2011 Aug;11(15):3169-89. doi: 10.1002/pmic.201000808. Epub 2011 Jul 4.
4
Proteomics of the heart: unraveling disease.心脏蛋白质组学:揭示疾病奥秘
Circ Res. 2006 Feb 17;98(3):309-21. doi: 10.1161/01.RES.0000201280.20709.26.
5
Analysis of Streptococcus pneumoniae secreted antigens by immuno-proteomic approach.免疫蛋白质组学方法分析肺炎链球菌分泌的抗原。
Diagn Microbiol Infect Dis. 2012 Apr;72(4):318-27. doi: 10.1016/j.diagmicrobio.2011.12.013. Epub 2012 Feb 4.
6
Proteomics: methodologies and applications in oncology.蛋白质组学:肿瘤学中的方法与应用
Semin Radiat Oncol. 2008 Apr;18(2):115-25. doi: 10.1016/j.semradonc.2007.10.008.
7
Proteomic analysis of the secretome of rice calli.水稻愈伤组织分泌蛋白质组分析。
Physiol Plant. 2009 Apr;135(4):331-41. doi: 10.1111/j.1399-3054.2008.01198.x. Epub 2009 Feb 17.
8
Group A streptococcal vaccines: facts versus fantasy.A 组链球菌疫苗:事实与幻想。
Curr Opin Infect Dis. 2009 Dec;22(6):544-52. doi: 10.1097/QCO.0b013e328332bbfe.
9
Developing antibacterial vaccines in genomics and proteomics era.基因组学和蛋白质组学时代的抗菌疫苗研发
Scand J Immunol. 2008 Jun;67(6):544-52. doi: 10.1111/j.1365-3083.2008.02107.x. Epub 2008 Apr 4.
10
Bacterial proteomics and identification of potential vaccine targets.细菌蛋白质组学与潜在疫苗靶标的鉴定。
Expert Rev Proteomics. 2010 Apr;7(2):181-4. doi: 10.1586/epr.10.12.

引用本文的文献

1
Fatal case of streptococcal prosthetic valve endocarditis caused by Streptococcus mitis in patient with tetralogy fallot disorder: a case report.法洛四联症患者由缓症链球菌引起的链球菌人工瓣膜心内膜炎致死病例:一例报告
J Cardiothorac Surg. 2025 May 21;20(1):233. doi: 10.1186/s13019-025-03463-1.
2
Streptococcal peptides and their roles in host-microbe interactions.链球菌肽及其在宿主-微生物相互作用中的作用。
Front Cell Infect Microbiol. 2023 Oct 16;13:1282622. doi: 10.3389/fcimb.2023.1282622. eCollection 2023.
3
Lactoferrin: A Critical Mediator of Both Host Immune Response and Antimicrobial Activity in Response to Streptococcal Infections.
乳铁蛋白:宿主免疫反应及抗链球菌感染抗菌活性的关键介质
ACS Infect Dis. 2020 Jul 10;6(7):1615-1623. doi: 10.1021/acsinfecdis.0c00050. Epub 2020 May 7.
4
Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With Deletion.血清型非依赖型肺炎链球菌侵袭性感染的活疫苗缺失株保护作用
Front Immunol. 2019 May 29;10:1212. doi: 10.3389/fimmu.2019.01212. eCollection 2019.
5
Towards developing a vaccine for rheumatic heart disease.致力于研发一种用于风湿性心脏病的疫苗。
Glob Cardiol Sci Pract. 2017 Mar 31;2017(1):e201704. doi: 10.21542/gcsp.2017.4.
6
Vaccination with Streptococcus pyogenes nuclease A stimulates a high antibody response but no protective immunity in a mouse model of infection.用化脓性链球菌核酸酶A进行疫苗接种在小鼠感染模型中可刺激产生高抗体反应,但无保护性免疫。
Med Microbiol Immunol. 2015 Apr;204(2):185-91. doi: 10.1007/s00430-014-0353-2. Epub 2014 Aug 15.
7
Disease manifestations and pathogenic mechanisms of Group A Streptococcus.A 组链球菌的疾病表现及致病机制
Clin Microbiol Rev. 2014 Apr;27(2):264-301. doi: 10.1128/CMR.00101-13.
8
The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus.纤连蛋白结合 M1 蛋白降低 M1T1 群 A 链球菌的咽部细胞黏附及定植表型。
J Biol Chem. 2014 Feb 7;289(6):3539-46. doi: 10.1074/jbc.M113.529537. Epub 2013 Dec 19.
9
The pathogenicity of the Streptococcus genus.链球菌属的致病性。
Eur J Clin Microbiol Infect Dis. 2013 Nov;32(11):1361-76. doi: 10.1007/s10096-013-1914-9. Epub 2013 Jul 3.
10
Group A streptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation.A 组链球菌半胱氨酸蛋白酶裂解上皮连接,有助于细菌易位。
J Biol Chem. 2013 May 10;288(19):13317-24. doi: 10.1074/jbc.M113.459875. Epub 2013 Mar 26.